BACKGROUND Few therapeutic options exist for patients with severe heart failure due to obstructive hypertrophic
D
ynamic left ventricular outflow tract (LVOT) obstruction occurs in 70% of patients with hypertrophic cardiomyopathy (HCM) and can be associated with disabling symptoms (1, 2) . Current therapies for severe, drug-refractory symptoms are surgical septal myectomy (the "gold standard") and alcohol septal ablation (a selective alternative), both of which target the ventricular septum to effectively reduce outflow gradients and relieve heart failure symptoms (3, 4) . Mitral valve surgery, consisting of either valve replacement or leaflet plication in conjunction with septal myectomy, has been used effectively in obstructive HCM (5, 6) . Notably, therapeutic targeting of the mitral valve has attracted renewed interest in obstructive HCM with the recent recognition that mitral leaflet elongation and enlargement is common in these patients (7) , and transaortic chordal cutting with shallow myectomy has been advanced as a novel surgical strategy (8) .
We hypothesized that percutaneous mitral valve plication could be effective in reducing systolic anterior motion (SAM) of the valve and associated mitral regurgitation (MR) in obstructive HCM, thereby providing an alternate strategy for relief of heart failure symptoms. Accordingly, we describe here our experience with percutaneous mitral valve plication using a transcatheter system (MitraClip, Percutaneous mitral valve plication with mitral clip implantation was performed using previously described techniques (11, 12) . In brief, a posteriorsuperior transseptal puncture from the right femoral vein was performed at a height of 3.5 to 4.0 cm above the mitral annular plane. Over a stiff wire, a 24-F guiding catheter was placed into the left atrium, followed by advancement of a steerable sleeve and clip delivery system. With guidance from transesophageal echocardiography, the clip delivery system was steered toward the mitral valve with alignment of clip arms perpendicular to the leaflet coaptation plane.
The clip was advanced into the left ventricle through a chord-free zone of the mitral valve, followed by Values are mean AE SD unless otherwise indicated. *Obtained at cardiac catheterization. †Obtained by echocardiography.
LAP ¼ left atrial pressure; other abbreviations as in Table 1 . Abbreviations as in Figure 1 . 
